• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biomarkers for Immune Checkpoint Inhibitor-Induced Myocarditis: Caution Needed.

作者信息

Jaffe Allan S

机构信息

Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

出版信息

JACC CardioOncol. 2022 Dec 20;4(5):701-703. doi: 10.1016/j.jaccao.2022.11.014. eCollection 2022 Dec.

DOI:10.1016/j.jaccao.2022.11.014
PMID:36636433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9830193/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce46/9830193/574050a20908/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce46/9830193/574050a20908/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce46/9830193/574050a20908/fx1.jpg

相似文献

1
Biomarkers for Immune Checkpoint Inhibitor-Induced Myocarditis: Caution Needed.免疫检查点抑制剂诱发心肌炎的生物标志物：需谨慎对待。
JACC CardioOncol. 2022 Dec 20;4(5):701-703. doi: 10.1016/j.jaccao.2022.11.014. eCollection 2022 Dec.
2
A Systematic Review of Myocarditis Induced by Immune Checkpoint Inhibitors: How Concerning Is the Most Common Cardiotoxicity of Immune Checkpoint Inhibitors?免疫检查点抑制剂诱发心肌炎的系统评价：免疫检查点抑制剂最常见的心脏毒性有多令人担忧？
Cureus. 2023 Jul 18;15(7):e42071. doi: 10.7759/cureus.42071. eCollection 2023 Jul.
3
Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.伊匹单抗和纳武利尤单抗致转移性胆管癌患者心肌炎：病例报告。
J Med Case Rep. 2022 Jul 14;16(1):275. doi: 10.1186/s13256-022-03487-4.
4
Prospective cardiovascular events in patients with advanced thoracic cancer treated with immune checkpoint inhibitor.晚期胸部恶性肿瘤患者接受免疫检查点抑制剂治疗后的预期心血管事件。
Eur J Cancer. 2024 Aug;207:114191. doi: 10.1016/j.ejca.2024.114191. Epub 2024 Jun 24.
5
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis.生物标志物在免疫检查点抑制剂相关心肌炎管理中的作用。
Curr Cardiol Rep. 2023 Sep;25(9):959-967. doi: 10.1007/s11886-023-01915-5. Epub 2023 Jul 12.
6
The role of circulating biomarkers in predicting the 30-day mortality of immune checkpoint inhibitors-related myocarditis: a retrospective cohort study.循环生物标志物在预测免疫检查点抑制剂相关性心肌炎 30 天死亡率中的作用：一项回顾性队列研究。
Intern Emerg Med. 2024 Mar;19(2):377-389. doi: 10.1007/s11739-023-03481-8. Epub 2023 Dec 12.
7
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.生物标志物趋势、免疫检查点抑制剂诱发心肌炎的发病率及转归
JACC CardioOncol. 2022 Dec 20;4(5):689-700. doi: 10.1016/j.jaccao.2022.11.004. eCollection 2022 Dec.
8
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis.免疫检查点抑制剂相关心肌炎患者的临床特征、病程、治疗和结局。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002553.
9
Successful management of camrelizumab-induced immune-checkpoint-inhibitors-related myocarditis.卡瑞利珠单抗相关免疫检查点抑制剂性心肌炎的成功治疗。
J Oncol Pharm Pract. 2024 Apr;30(3):597-604. doi: 10.1177/10781552231216104. Epub 2023 Dec 3.
10
Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-related myocarditis and myositis: rechallenge?肌钙蛋白 T 与 I 在免疫检查点抑制剂相关心肌炎和肌炎诊断中的价值：再挑战？
ESC Heart Fail. 2023 Aug;10(4):2680-2685. doi: 10.1002/ehf2.14360. Epub 2023 Apr 6.

引用本文的文献

1
Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitors.接受免疫检查点抑制剂治疗的癌症患者心脏炎症不良事件的时间依赖性预测因素。
Cardiooncology. 2025 Apr 28;11(1):40. doi: 10.1186/s40959-025-00331-8.
2
Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach.循环生物标志物在免疫检查点抑制剂相关心肌炎诊断和预后中的应用：基于风险的方法时机已到。
Front Cardiovasc Med. 2024 Feb 12;11:1350585. doi: 10.3389/fcvm.2024.1350585. eCollection 2024.

本文引用的文献

1
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.生物标志物趋势、免疫检查点抑制剂诱发心肌炎的发病率及转归
JACC CardioOncol. 2022 Dec 20;4(5):689-700. doi: 10.1016/j.jaccao.2022.11.004. eCollection 2022 Dec.
2
Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection.巨肌钙蛋白复合物作为新冠病毒疫苗接种和感染后心肌肌钙蛋白升高的原因
Clin Chem. 2022 Jul 27;68(8):1015-1019. doi: 10.1093/clinchem/hvac100.
3
Which method to detect macrotroponin?检测巨肌钙蛋白采用哪种方法？
Clin Chem Lab Med. 2022 Jan 11;60(3):68-70. doi: 10.1515/cclm-2021-1330. Print 2022 Feb 23.
4
Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.癌症患者中免疫检查点抑制剂诱导的心肌炎：一例病例报告及已报道病例综述
Cardiooncology. 2021 Aug 9;7(1):27. doi: 10.1186/s40959-021-00114-x.
5
Review of immune checkpoint inhibitors in immuno-oncology.免疫检查点抑制剂在肿瘤免疫治疗中的研究进展。
Adv Pharmacol. 2021;91:111-139. doi: 10.1016/bs.apha.2021.01.002. Epub 2021 May 20.
6
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.与免疫检查点阻断相关的免疫相关不良事件。
N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481.
7
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.暴发性心肌炎合并免疫检查点阻断治疗
N Engl J Med. 2016 Nov 3;375(18):1749-1755. doi: 10.1056/NEJMoa1609214.
8
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.癌症患者的心血管生物标志物及其与全因死亡率的关联。
Heart. 2015 Dec;101(23):1874-80. doi: 10.1136/heartjnl-2015-307848. Epub 2015 Sep 28.
9
Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates.与心肌炎相关的心肌肌钙蛋白I升高。实验与临床关联
Circulation. 1997 Jan 7;95(1):163-8.
10
Serum troponin T: diagnostic marker for acute myocarditis.
Clin Chem. 1996 Feb;42(2):340-1.